Clinical Trial Update: A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy, safety, and quality-of-life impact of Dilaudid CR (hydromorphone hydrochloride) in patients with chronic low back pain …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Dilaudid CR (hydromorphone hydrochloride)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Low Back Pain | Phase 2 | Status: COMPLETED